No Data
Toyokumo, Kaiomu, and others [Emerging Markets Press Release]
Termination of agreement between ＜3224＞ G Oyster Nexta (Nexta anonymous consortium operator) ＜4058＞ Toyokumo off-floor allotment, 0.12 million shares ＜4576＞ DWTI 12th new share subscription rights (with exercise price adjustment clause) massive exercise, number of shares to be delivered from the 20th, 1.75 million shares ＜4583＞ Kaiomu pharmaceutical, engaged in business in the field of diagnostic drugs, signs an exclusive licensing agreement with Asahi Kasei Pharma for anti-CX3CR1 antibodies ＜5247＞ Establishes a subsidiary of BTM ＜6573>
General Oyster: Extraordinary Report
General Oyster 1H Loss Y23.00M Vs Loss Y14.00M
General Oyster: Presentation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025
General Oyster: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)
General Oyster: Half Year Report - 25th Term (2024/04/01 - 2025/03/31)
No Data
No Data